Company Overview

Update
Founded:
2007
Headquarters:
Cleveland, OH
Funding:
$39.20M
Categories:
Biotechnology

Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.

Description

Update

Juventas Therapeutics, headquartered in Cleveland, OH, is a privately-held clinical-stage biotechnology company developing a pipeline of regenerative therapies to treat life–threatening diseases. Founded in 2007 with an exclusive license from the Cleveland Clinic, Juventas has transitioned its therapeutic platform from concept to initiation of mid-stage clinical trials. Investors include Triathlon Medical Venture Partners, Early Stage Partners, Fletcher Spaght Ventures, Reservoir Venture Partners, North Coast Angel Fund, X Gen Ltd., JumpStart Inc., and Blue Chip Venture Co. The company has received nondilutive grant support through the Ohio Third Frontier funded Cleveland Clinic Ohio BioValidation Fund, Global Cardiovascular Innovation Center and Center for Stem Cell & Regenerative Medicine.

Current Team (4)

Update

Board Members and Advisors (4)

Update

Funding Rounds (3) - $39.20M

Update

Investors (8)

Update

Offices/Locations (1)

Update
  • HQ

    3615 Superior Avenue,

    Suite 4403C

    Cleveland, OH 44114

    USA